Vontobel Holding
ACET icon

Vontobel Holding’s Adicet Bio ACET Stock Holding History

Vontobel Holding’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Sell
13,776
-471
-3% -$3.71K ﹤0.01% 1396
2026
Q1 		$97K Buy
+14,247
New +$107K ﹤0.01% 1149
2025
Q4 		– Sell
-5,000
Closed -$65.2K – 1433
2025
Q3 		$65.2K Hold
5,000
– – ﹤0.01% 1314
2025
Q2 		$48.8K Buy
5,000
+1,250
+33% +$13.2K ﹤0.01% 1235
2025
Q1 		$46.6K Buy
3,750
+625
+20% +$8.94K ﹤0.01% 1064
2024
Q4 		$48.1K Buy
3,125
+625
+25% +$11.8K ﹤0.01% 1075
2024
Q3 		$57.6K Hold
2,500
– – ﹤0.01% 1056
2024
Q2 		$48.4K Buy
2,500
+812
+48% +$21.8K ﹤0.01% 1044
2024
Q1 		$63.5K Buy
+1,688
New +$69.8K ﹤0.01% 1044

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Vontobel Holding's ACET Position: Q2 2026 in Review

Vontobel Holding reduced its Adicet Bio (ACET) stake by 3.3% in Q2 2026, selling an estimated $3.71K and leaving 13,776 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #1396.

Vontobel Holding first reported a position in ACET in Q1 2024 and has held it in 9 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Vontobel Holding held 13,776 shares of Adicet Bio worth $119K as of Q2 2026.
  • Vontobel Holding sold 471 Adicet Bio shares in Q2 2026, an estimated $3.71K.
  • Adicet Bio made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1396 holding.
  • Vontobel Holding first reported a position in Adicet Bio in Q1 2024 and has held it in 9 quarters since.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.